LeMaitre Vascular (LMAT) Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Do institutionals and insiders have more ownership in STVN or LMAT?

84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Stevanato Group shares are held by insiders. Comparatively, 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is STVN or LMAT more profitable?

LeMaitre Vascular has a net margin of 19.96% compared to Stevanato Group's net margin of 11.14%. LeMaitre Vascular's return on equity of 13.53% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.14%	10.00%	6.03%
LeMaitre Vascular	19.96%	13.53%	9.78%

Does the media refer more to STVN or LMAT?

In the previous week, Stevanato Group had 6 more articles in the media than LeMaitre Vascular. MarketBeat recorded 7 mentions for Stevanato Group and 1 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.86 beat Stevanato Group's score of 0.58 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, STVN or LMAT?

Stevanato Group has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.

Which has stronger earnings and valuation, STVN or LMAT?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.19B	6.23	€127.45M	€0.51	48.22
LeMaitre Vascular	$219.86M	8.67	$44.04M	$1.98	42.63

Do analysts prefer STVN or LMAT?

LeMaitre Vascular has a consensus target price of $97.83, suggesting a potential upside of 15.90%. Given LeMaitre Vascular's higher possible upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

LeMaitre Vascular beats Stevanato Group on 10 of the 17 factors compared between the two stocks.